Catherine Matthes is Founder and Managing Member of MedFINiti LLC which she formed to focus on providing contracted financial and strategic consulting services to businesses, most specifically in the venture-backed, life sciences and medtech sectors.
Before starting MedFINiti, Cathy worked for almost eight years as CFO for Veniti, Inc., a venous stent company, for which she managed operations and drove fundraising, strategic planning and eventually the sale of the company to Boston Scientific in 2018. Prior to Veniti, Cathy amassed over 24 years’ experience across a range of leadership, business development and operational roles in both large and start-up life science companies. During this time, she was co-founder and CFO of Galera Therapeutics which recently announced their IPO (Nasdaq: GRTX).
Cathy is also a Certified Public Accountant in the state of Missouri and holds a BSBA from the University of Missouri.